secwatch.observer — SEC 8-K summary
======================================

Issuer:     THERMO FISHER SCIENTIFIC INC. (TMO)
CIK:        0000097745
Form:       8-K
Filed at:   2024-07-24T23:59:59+00:00
Accession:  0000097745-24-000036
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Thermo Fisher Q2 GAAP EPS $4.04 (+15%), Adj. EPS $5.37 (+4%), raises FY 2024 guidance
--------------------------------------------------------------------------------

- Revenue $10.54B, down 1% YoY; organic revenue -1%, core organic revenue flat.
- GAAP operating margin improved to 17.3% from 14.8%; adjusted operating margin 22.3% vs 22.2%.
- Completed Olink acquisition post-quarter to extend proteomics capabilities.
- Raised FY 2024 revenue guidance to $42.4-43.3B (prev. $42.3-43.3B) and adj. EPS to $21.29-22.07 (prev. $21.14-22.02).
- Launched multiple new instruments including Stellar mass spec and biobased bioprocessing film.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/97745/000009774524000036/0000097745-24-000036-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/97745/000009774524000036/tmo-20240724.htm
  HTML page:      https://secwatch.observer/filing/0000097745-24-000036

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer